Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair–Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy
Gabriele Picco, Chiara M. Cattaneo, Esmée J. van Vliet, et al.
Cancer Discovery (2021) Vol. 11, Iss. 8, pp. 1923-1937
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

CRISPR in cancer biology and therapy
Alyna Katti, Bianca J. Diaz, Christina M. Caragine, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 259-279
Open Access | Times Cited: 291
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
Kristen A. Baltgalvis, Kelsey N. Lamb, Kent T. Symons, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 435-442
Closed Access | Times Cited: 33
Synthetic lethality of mRNA quality control complexes in cancer
Vivian Prindle, Adam E. Richardson, Kenneth J. Sher, et al.
Nature (2025)
Open Access | Times Cited: 4
Lynch Syndrome and MSI-H Cancers: From Mechanisms to “Off-The-Shelf” Cancer Vaccines
Vladimir Roudko, Cansu Cimen Bozkus, Benjamin Greenbaum, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 67
Therapeutic and prognostic insights from the analysis of cancer mutational signatures
Samuel W. Brady, Alexander M. Gout, Jinghui Zhang
Trends in Genetics (2021) Vol. 38, Iss. 2, pp. 194-208
Open Access | Times Cited: 66
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes
Wantao Wu, Yihan Liu, Shan Zeng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 57
Resistance to DNA repair inhibitors in cancer
Joseph S. Baxter, Diana Zatreanu, Stephen J. Pettitt, et al.
Molecular Oncology (2022) Vol. 16, Iss. 21, pp. 3811-3827
Open Access | Times Cited: 53
SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
Min Wei, Xinping Huang, Liming Liao, et al.
Cancer Research (2023) Vol. 83, Iss. 17, pp. 2908-2923
Closed Access | Times Cited: 41
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells
Gabriele Picco, Yanhua Rao, Angham Al Saedi, et al.
Cancer Discovery (2024) Vol. 14, Iss. 8, pp. 1457-1475
Closed Access | Times Cited: 15
Comprehensive genomic dependency landscape of a human colon cancer organoid
Sana Khalili, Atefeh Mohseninia, Changlong Liu, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Tumor-agnostic drug development in dMMR/MSI-H solid tumors
Deepak Bhamidipati, Vivek Subbiah
Trends in cancer (2023) Vol. 9, Iss. 10, pp. 828-839
Open Access | Times Cited: 20
Clinical Evaluation of the Pancreatic Cancer Microenvironment: Opportunities and Challenges
Julianne M. Szczepanski, Mark A. Rudolf, Jiaqi Shi
Cancers (2024) Vol. 16, Iss. 4, pp. 794-794
Open Access | Times Cited: 7
The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
Meiyi Ge, Jian Luo, Yi Wu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer
Wenxuan Fan, Fei Su, Yan Zhang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Multifunctional CaCO3@Cur@QTX125@HA nanoparticles for effectively inhibiting growth of colorectal cancer cells
Shengyun Hu, Kunkun Xia, Xiaobei Huang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients
Andrew Everall, Avraam Tapinos, Aliah Hawari, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 14
WRN helicase and mismatch repair complexes independently and synergistically disrupt cruciform DNA structures
Valentina Mengoli, Ilaria Ceppi, Aurore Sanchez, et al.
The EMBO Journal (2022) Vol. 42, Iss. 3
Open Access | Times Cited: 20
ATR inhibition induces synthetic lethality in mismatch repair-deficient cells and augments immunotherapy
Mingchao Wang, Xiaojuan Ran, Wendy Leung, et al.
Genes & Development (2023) Vol. 37, Iss. 19-20, pp. 929-943
Open Access | Times Cited: 12
Design and synthesis of N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as potential Werner-dependent antiproliferative agents
Huimin Li, Jia Yu, Gang Yu, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 4
Synthetic lethal strategies for the development of cancer therapeutics
Natalie Ngoi, David Gallo, C. Sevillano, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 4
Synergistic enhancement of PARP inhibition via small molecule UNI66-mediated suppression of BRD4-dependent transcription of RAD51 and CtIP
Enkhzul Amarsanaa, Minwoo Wie, Unbeom Shin, et al.
NAR Cancer (2025) Vol. 7, Iss. 2
Open Access
Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair
Jeremy M. Kelm, Amirreza Samarbakhsh, Athira Pillai, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
Bufalin-Loaded Multifunctional Photothermal Nanoparticles Inhibit the Anaerobic Glycolysis by Targeting SRC-3/HIF-1α Pathway for Improved Mild Photothermal Therapy in CRC
Jing Shang, Qi Xia, Yuji Sun, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7831-7850
Open Access | Times Cited: 3
Combined KRAS and TP53 mutation in patients with colorectal cancer enhance chemoresistance to promote postoperative recurrence and metastasis
YiMeng Tang, Fan Yao
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Crystal-Storing Histiocytosis of Multiple Myeloma with A Novel Multi-Exon Deletion of WRN: A Case Report and Mini Review of Literature
Tian Wei, Mengjun Zhong, Jingfu Li, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155921-155921
Closed Access
Page 1 - Next Page

Scroll to top